Search | PALTmed

Showing 5291 - 5300 of 9004 results

On-Demand

Module 1: Design Your Deprescribing Intervention

Drive to Deprescribe: In the post-acute and long-term care (PALTC) setting, managing medications effectively is crucial for optimizing patient outcomes and minimizing harm. Despite the importance of deprescribing, many providers face challenges in this area. This interactive course is designed to equip you with the skills and knowledge necessary to implement effective deprescribing practices in your facility.

On-Demand

Module 2: Deprescribing Communication Techniques

Drive to Deprescribe: Learn how to engage PALTC residents and their families in effective conversations about medication deprescribing with this 30-minute, interactive course.

On-Demand

Module 3: Optimizing Use of Antipsychotic Medications

JAMDA

July 20, 2021

Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase–Producing in Long-Term Care ResidentsEnterobacteralesMolecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase–Producing in Long-Term Care Residents

We aimed to assess the burden of extended-spectrum β-lactamase (ESBL)-producing in Swiss long-term care facilities (LTCFs) to describe the molecular epidemiology, describe the intrainstitutional and regional clusters of resistant pathogens, and identify independent institution- and resident-level factors ...

JAMDA

February 22, 2022

Monitoring Laboratory Parameters for Drug Toxicity in Assisted Living Facilities

JAMDA

November 1, 2021

Monoclonal Antibody Use in Post-Acute and Long-Term Care: A Call to Action

JAMDA

February 19, 2015

Mood Stabilization Therapy for Sexually Inappropriate Behavior

JAMDA

February 23, 2017

Morbid Obesity, Multi-morbidity and Malnutrition - A Therapeutic Challenge in the Post Acute and Long Term Care Settings

Policy Snapshot

May 31, 2024

Morbidity and Mortality Weekly Report — Early Safety Findings Among Persons Aged 60 Years and Older Who Received a Respiratory Syncytial Virus Vaccine — United States, May 3, 2023–April 14, 2024

A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.

JAMDA

January 14, 2020

Morbidity Measures Predicting Mortality in Inpatients: A Systematic Review

Morbidity is an important risk factor for mortality and a variety of morbidity measures have been developed to predict patients' health outcomes. The objective of this systematic review was to compare the capacity of morbidity measures in predicting mortality among inpatients admitted to internal medi...